NCT01020175View on ClinicalTrials.gov

Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

January 31, 1995

Primary Completion Date

December 31, 1999

Study Completion Date

December 31, 2002

Conditions
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome
Interventions
PROCEDURE

Bone marrow transplantation

Patients received bone marrow transplantation

PROCEDURE

Peripheral blood stem cell transplantation

Patients received filgrastim-mobilized peripheral blood stem cell transplantation

Trial Locations (1)

20099

Dr. Norbert Schmitz, Hamburg

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

European Society for Blood and Marrow Transplantation

NETWORK